🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Shares

Tesla, Carnival, Polestar fall premarket; Paramount Global rises

Published 02/07/2024, 12:44
© Reuters
BA
-
PARA
-
TSLA
-
INCY
-
CCL
-
NCLH
-
PSTG
-
CRWD
-
PSNY
-

Investing.com -- U.S. stock futures slipped lower Tuesday, consolidating from record levels ahead of jobs data and a speech from Fed chair Jerome Powell.

Here are some of the biggest premarket U.S. stock movers today:

  • Tesla (NASDAQ:TSLA) stock fell 1.6% after the EV manufacturer’s June sales of China-made electric vehicles fell 24.2% from a year earlier, data from the China Passenger Car Association showed on Tuesday.

  • Paramount Global (NASDAQ:PARA) stock rose 3.1% after the New York Times reported that the billionaire Barry Diller is considering a bid to take over the company after the studio he formerly led pulled out of a merger with Skydance Media.

  • Boeing (NYSE:BA) stock fell 0.4% after the Associated Press reported that the U.S. Justice Department is waiting for the planemaker to accept a plea deal to settle felony fraud charges related to two fatal crashes of its 737 Max planes.

  • Carnival (NYSE:CCL) stock fell 1.1% and Norwegian Cruise Line (NYSE:NCLH) dropped 1.2% as Hurricane Beryl worked its way through the Caribbean, potentially disrupting cruise activity.

  • Polestar (NASDAQ:PSNY) stock fell 5% after the EV maker posted a first-quarter operating loss, adding that it will have to take steps to offset hefty EU and U.S. import tariffs on its Chinese-made electric cars.

  • Pure Storage (NYSE:PSTG) stock fell 5% after UBS downgraded the company, which develops all-flash data storage hardware and software products, to “sell” from “neutral”, highlighting concerns over slowing growth, market share decline, and an overvalued stock price.

  • CrowdStrike (NASDAQ:CRWD) stock slipped 2.5% after Piper Sandler downgraded its stance on the cybersecurity firm to "neutral" from "overweight", citing valuation concerns, saying risk/reward is less “favorable”.

  • Incyte (NASDAQ:INCY) stock fell 3.1% after BMO Capital Markets downgraded the pharmaceutical group to "underperform" from "market perform", citing concerns that revenues from its key eczema cream Opzelura would likely be "challenged".

Feel ready to dive into details and start finding interesting stocks to invest? Try our AI supported solution InvestingPro today!

Get an extra discount up to 10% by applying the code UK10 on our 1&2 year plans. Don't wait any longer!

How to buy pro InvestingPro

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.